news.bloombergtax.com·1 min read
UK Set to Miss Out on Off-Patent Drug Savings, Lobby Group Warns
A
Ashleigh Furlong
The UK will miss out on savings worth hundreds of millions of pounds on off-patent medicines, an industry group warned, with drugmakers put off by concerns around pricing and lack of usage in the National Health Service.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in